7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline
AssigneeAllergan, Inc.
InventorsKen Chow, Todd Heidelbaugh, Phong Nguyen, Dale Harcourt
Life of this patent
Estimating the term…
Abstract
A compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
Claims19
A compound having a structure
- or a pharmaceutically acceptable salt, or a prodrug thereof.
A composition comprising a compound having a structure
- wherein said compound may be in neutral form, a salt form, or a combination thereof.
A method comprising administering a composition to a mammal, said method being effective for the treatment of glaucoma or ocular hypertension, wherein said composition has comprises an enantiomeric excess of the (+) entantiomer of one or more of a compound, a salt of the compound, a prodrug of the compound, and a combination thereof;
- said compound having the formula
A compound having the name 7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline, or a pharmaceutically acceptable salt, or a prodrug thereof.
Dependencies are inferred from the claim text.